Correlation Between GSK Plc and Roche Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GSK Plc and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GSK Plc and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GSK plc and Roche Holding Ltd, you can compare the effects of market volatilities on GSK Plc and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GSK Plc with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of GSK Plc and Roche Holding.

Diversification Opportunities for GSK Plc and Roche Holding

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between GSK and Roche is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding GSK plc and Roche Holding Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding and GSK Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GSK plc are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding has no effect on the direction of GSK Plc i.e., GSK Plc and Roche Holding go up and down completely randomly.

Pair Corralation between GSK Plc and Roche Holding

Assuming the 90 days horizon GSK plc is expected to under-perform the Roche Holding. In addition to that, GSK Plc is 2.72 times more volatile than Roche Holding Ltd. It trades about -0.12 of its total potential returns per unit of risk. Roche Holding Ltd is currently generating about -0.15 per unit of volatility. If you would invest  3,921  in Roche Holding Ltd on September 16, 2024 and sell it today you would lose (382.00) from holding Roche Holding Ltd or give up 9.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GSK plc  vs.  Roche Holding Ltd

 Performance 
       Timeline  
GSK plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GSK plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Roche Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

GSK Plc and Roche Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GSK Plc and Roche Holding

The main advantage of trading using opposite GSK Plc and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GSK Plc position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.
The idea behind GSK plc and Roche Holding Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency